Related references
Note: Only part of the references are listed.TNF-α is critical for antitumor but not antiviral T cell immunity in mice
Thomas Calzascia et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer
Lin Zhang et al.
CLINICAL CANCER RESEARCH (2007)
Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling
Chrystal M. Paulos et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Integrating epitope data into the emerging web of biomedical knowledge resources
Bjoern Peters et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Identification of T-cell epitopes for cancer immunotherapy
J. H. Kessler et al.
LEUKEMIA (2007)
Dendritic cell targeting of survivin protein in a xenogeneic form elicits strong CD4+ T cell immunity to mouse survivin
Anna Charalambous et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Adoptive immunotherapy for cancer: building on success
L Gattinoni et al.
NATURE REVIEWS IMMUNOLOGY (2006)
A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells
S Ottaviani et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma
SA Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2005)
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells
L Gattinoni et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immunotherapy for gynaecological malignancies
G Coukos et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Vaccine-stimulated, adoptively transferred CD8+ T cells traffic indiscriminately and ubiquitously while mediating specific tumor destruction
DC Palmer et al.
JOURNAL OF IMMUNOLOGY (2004)
Cytokines in cancer immunity and immunotherapy
MJ Smyth et al.
IMMUNOLOGICAL REVIEWS (2004)
TCR affinity and negative regulation limit autoimmunity
MA Gronski et al.
NATURE MEDICINE (2004)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Five new human cancer-germline genes identified among 12 genes expressed in spermatogonia
A Loriot et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Ocular immune privilege: Therapeutic opportunities from an experiment of nature
JW Streilein
NATURE REVIEWS IMMUNOLOGY (2003)
Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues
AA Jungbluth et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Melanocyte destruction after antigen-specific immunotherapy of melanoma: Direct evidence of T cell-mediated vitiligo
C Yee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies
K Nagaraju et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
T cell immune responses against melanoma and melanocytes in cancer and autoimmunity
Y Kawakami et al.
PIGMENT CELL RESEARCH (2000)
Share Paper
